Quality of life under maintenance treatment with heroin versus methadone in patients with opioid dependence

Drug and Alcohol Dependence

Volumn 112, Issue 3, 2010, Pages 209-215

  Karow, A ^a   Reimer, J ^a   Schafer I ^a   Krausz, M ^b   Haasen, C ^a   Verthein, U ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Diamorphine; Heroin; Methadone; Opioid dependence; Psychosocial treatment; Quality of life

Indexed keywords

DIAMORPHINE; METHADONE;

ADULT; ARTICLE; CASE MANAGEMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LONGITUDINAL STUDY; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPIATE ADDICTION; OUTCOME ASSESSMENT; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; PSYCHOTHERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; CASE MANAGEMENT; COUNSELING; EDUCATION; FEMALE; HEROIN; HEROIN DEPENDENCE; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; METHADONE; MIDDLE AGED; NARCOTICS; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; YOUNG ADULT;

EID: 78649654329     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2010.06.009     Document Type: Article

References (47)

1. Addington J., Young J., Addington D. Social outcome in early psychosis. Psychol. Med. 2003, 33:1119-1124.
2. Amato L., Minozzi S., Davoli M., Vecchi S., Ferri M.M., Mayet S. Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. Cochr. Database Syst. Rev. 2008, CD004147.
3. Andrews F.M., Withey S.B. Social Indicators of Well-Being. Americans' Perceptions of Life Quality 1976, In Plenum, New York.
4. Astals M., Domingo-Salvany A., Buenaventura C.C., Tato J., Vazquez J.M., Martin-Santos R., Torrens M. Impact of substance dependence and dual diagnosis on the quality of life of heroin users seeking treatment. Subst. Use Misuse. 2008, 43:612-632.
5. Batki S.L., Canfield K.M., Smyth E., Ploutz-Snyder R. Health-related quality of life in methadone maintenance patients with untreated hepatitis C virus infection. Drug Alcohol Depend. 2009, 101:176-182.
6. Bizzarri J., Rucci P., Vallotta A., Girelli M., Scandolari A., Zerbetto E., Sbrana A., Iagher C., Dellantonio E. Dual diagnosis and quality of life in patients in treatment for opioid dependence. Subst. Use Misuse. 2005, 40:1765-1776.
7. Brogly S., Mercier C., Bruneau J., Palepu A., Franco E. Towards more effective public health programming for injection drug users: development and evaluation of the injection drug user quality of life scale. Subst. Use Misuse. 2003, 38:965-992.
8. Bullinger M. Assessing health related quality of life in medicine. An overview over concepts, methods and applications in international research. Restor. Neurol. Neurosci. 2002, 20:93-101.
9. Croog S.H., Levine S., Testa M.A., Brown B., Bulpitt C.J., Jenkins C.D., Klerman G.L., Williams G.H. The effects of antihypertensive therapy on the quality of life. N. Engl. J. Med. 1986, 314:1657-1664.
10. Darke S., Hall W., Wodak A., Heather N., Ward J. Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index. Br. J. Addict. 1992, 87:733-742.
11. Darke S., Ward J., Zador D., Swift G. A scale for estimating the health status of opioid users. Br. J. Addict. 1991, 86:1317-1322.
12. Derogatis, L.R., 1983. SCL-90-R: administration, scoring and procedures. Manual II. In Towsen MD: Clinical Psychometric Research.
13. Derogatis L.R., Rickels K., Rock A.F. The SCL-90 and the MMPI: a step in the validation of a new self-report scale. Br. J. Psychiatry 1976, 128:280-289.
14. Eklund C., Melin L., Hiltunen A., Borg S. Detoxification from methadone maintenance treatment in Sweden: long-term outcome and effects on quality of life and life situation. Int. J. Addict. 1994, 29:627-645.
15. Franke, G., 1995. SCL-90-R. Die Symptom-Checkliste von Derogatis. Deutsche Version. In Beltz-Test.: Göttingen.
16. Giacomuzzi S.M., Riemer Y., Kemmler G., Ertl M., Richter R., Rossler H., Hinterhuber H. Subjective wellbeing and somatic markers in methadone substitution. Evaluation of 61 heroin addicts. Fortschr. Med. Orig. 2001, 119:103-108.
17. Haasen C., Eiroa-Orosa F.J., Verthein U., Soyka M., Dilg C., Schafer I., Reimer J. Effects of heroin-assisted treatment on alcohol consumption: findings of the German randomized controlled trial. Alcohol 2009, 43:259-264.
18. Haasen C., Verthein U., Degkwitz P., Berger J., Krausz M., Naber D. Heroin-assisted treatment for opioid dependence: randomised controlled trial. Br. J. Psychiatry 2007, 191:55-62.
19. Hubley A.M., Palepu A. Injection Drug User Quality of Life Scale (IDUQOL): findings from a content validation study. Health Qual. Life Outcomes 2007, 5:46.
20. Karow A., Verthein U., Krausz M., Schafer I. Association of personality disorders, family conflicts and treatment with quality of life in opiate addiction. Eur. Addict. Res. 2008, 14:38-46.
21. Kastelic A., Dubajic G., Strbad E. Slow-release oral morphine for maintenance treatment of opioid addicts intolerant to methadone or with inadequate withdrawal suppression. Addiction 2008, 103:1837-1846.
22. Kokkevi A., Hartgers C. EuropASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence. Eur. Addict. Res. 1995, 208-210.
23. Korthuis P.T., Zephyrin L.C., Fleishman J.A., Saha S., Josephs J.S., McGrath M.M., Hellinger J., Gebo K.A. Health-related quality of life in HIV-infected patients: the role of substance use. AIDS Patient Care STDS 2008, 22:859-867.
24. Laudet A.B., Becker J.B., White W.L. Don't wanna go through that madness no more: quality of life satisfaction as predictor of sustained remission from illicit drug misuse. Subst. Use Misuse. 2009, 44:227-252.
25. Lehman A.F. Measures of quality of life among persons with severe and persistent mental disorders. Soc. Psychiatry Psychiatr. Epidemiol. 1996, 31:78-88.
26. Löbmann R., Verthein U. Explaining the effectiveness of heroin-assisted treatment on crime reductions. Law Hum. Behav. 2009, 33:83-95.
27. Maremmani I., Pani P.P., Pacini M., Perugi G. Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients. J. Subst. Abuse Treat. 2007, 33:91-98.
28. Miller P.G., Miller W.R. What should we be aiming for in the treatment of addiction?. Addiction 2009, 104:685-686.
29. Morales-Manrique C.C., Valderrama-Zurian J.C., Castellano-Gomez M., Aleixandre-Benavent R., Palepu A. Cross cultural adaptation of the Injection Drug User Quality Of Life Scale (IDUQOL) in Spanish drug dependent population, with or without injectable consumption: Drug User Quality of Life Scale-Spanish (DUQOL-Spanish). Addict. Behav. 2007, 32:1913-1921.
30. Perneger T.V., Giner F., del Rio M., Mino A. Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments. BMJ 1998, 317:13-18.
31. Ponizovsky A.M., Grinshpoon A. Quality of life among heroin users on buprenorphine versus methadone maintenance. Am. J. Drug Alcohol Abuse 2007, 33:631-642.
32. Priebe S., Roeder-Wanner U.U., Kaiser W. Quality of life in first-admitted schizophrenia patients: a follow-up study. Psychol. Med. 2000, 30:225-230.
33. Pukrop R., Moller H.J., Steinmeyer E.M. Quality of life in psychiatry: a systematic contribution to construct validation and the development of the integrative assessment tool "modular system for quality of life" Eur. Arch. Psychiatry Clin. Neurosci. 2000, 250:120-132.
34. Pukrop R., Schlaak V., Moller-Leimkuhler A.M., Albus M., Czernik A., Klosterkotter J., Moller H.J. Reliability and validity of quality of life assessed by the short-form 36 and the modular system for quality of life in patients with schizophrenia and patients with depression. Psychiatry Res. 2003, 119:63-79.
35. Rajaratnam R., Sivesind D., Todman M., Roane D., Seewald R. The aging methadone maintenance patient: treatment adjustment, long-term success, and quality of life. J. Opioid Manag. 2009, 5:27-37.
36. Reno R.R., Aiken L.S. Life activities and life quality of heroin addicts in and out of methadone treatment. Int. J. Addict. 1993, 28:211-232.
37. Richter D., Eikelmann B., Berger K. Use of the SF-36 in the evaluation of a drug detoxification program. Qual. Life Res. 2004, 13:907-914.
38. Ruhrmann S., Paruch J., Bechdolf A., Pukrop R., Wagner M., Berning J., Schultze-Lutter F., Janssen B., Gaebel W., Moller H.J., Maier W., Klosterkotter J. Reduced subjective quality of life in persons at risk for psychosis. Acta Psychiatr. Scand. 2008, 117:357-368.
39. Schäfer A., Wittchen H.U., Backmund M., Soyka M., Golz J., Siegert J., Schäfer M., Tretter F., Kraus M.R. Psychopathological changes and quality of life in hepatitis C virus-infected, opioid-dependent patients during maintenance therapy. Addiction 2009, 104:630-640.
40. Schwartz R.P., Brooner R.K., Montoya I.D., Currens M., Hayes M. A 12-year follow-up of a methadone medical maintenance program. Am. J. Addict. 1999, 8:293-299.
41. Torrens M., Domingo-Salvany A., Alonso J., Castillo C., San L. Methadone and quality of life. Lancet 1999, 353:1101.
42. Torrens M., San L., Martinez A., Castillo C., Domingo-Salvany A., Alonso J. Use of the Nottingham Health Profile for measuring health status of patients in methadone maintenance treatment. Addiction 1997, 92(June (6)):707-716.
43. Ventegodt S., Merrick J. Psychoactive drugs and quality of life. ScientificWorldJournal 2003, 3:694-706.
44. Verthein U., Degkwitz P., Haasen C., Krausz M. Significance of comorbidity for the long-term course of opiate dependence. Eur. Addict. Res. 2005, 11:15-21.
45. Verthein U., Degkwitz P., Haasen C., 2008. Die Wirksamkeit der Diamorphinbehandlung im Vergleich zur Methadonsubstitution - Ergebnisse der 1. und 2. Studienphase. In: Bundesministerium für Gesundheit (BMG) (Hrsg.) Das bundesdeutsche Modellprojekt zur heroingestützten Behandlung Opiatabhängiger. Band 1. Baden-Baden: Nomos.
46. Wasserman D.A., Sorensen J.L., Delucchi K.L., Masson C.L., Hall S.M. Psychometric evaluation of the Quality of Life Interview, Brief Version, in injection drug users. Psychol. Addict. Behav. 2006, 20:316-321.
47. World Health Organization (1993) The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. WHO.